A qualitative study to assess the perceived benefits and barriers to the pneumococcal vaccine in hospitalised older people.


UNLABELLED Pneumococcal vaccine is now recommended for all people aged 65 years and over in Australia, yet many in this age group remain unvaccinated, especially those from Non-English Speaking Backgrounds (NESB). AIM Our aim was to assess some of the perceived beliefs, benefits and barriers to pneumococcal immunisation in older people. DESIGN AND… (More)
DOI: 10.1016/j.vaccine.2009.03.075


2 Figures and Tables

Slides referencing similar topics